Clinical Trial Update: Dipyridamole/Magnesium To Improve Sickle Cell Hydration [Phase 2]

View source ↗

Summary

Phase 2 trial of dipyridamole with magnesium to improve hydration in sickle cell disease was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Dipyridamole (Dipyridamole)
• Magnesium (magnesium)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Anemia, Sickle Cell | Phase 2 | Status: WITHDRAWN